To resolve all these issues, future mechanistic studies should be directed toward identifying the regulatory networks and target specificities of lnc-IRF2-3 and lnc-KIAA1755-4 in CLL cells. The gene discussed is IRF2; the disease is B-cell chronic lymphocytic leukemia.